% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • ivoroshea ivoroshea Aug 23, 2010 2:25 PM Flag

    Azixa Phase II Trial Suspended

    I was doing some DD on this stock on the basis today's fall may be overdone.

    However, I noticed on that their Azixa Phase II trial on Glioblastoma Multiforme (brain cancer) was marked down as suspended last Thursday, 19 August. The trial's Identifier is NCT00892931 if you wish to verify this.

    Oddly, neither Epicept or their partner, Myrexis, have made any comment on this development.

    To be fair, until the background to the suspension is explained, it's not fully clear what the implications are. However, it has to be marked down as a negative development as of right now. It never rains but it pours ...

    SortNewest  |  Oldest  |  Most Replied Expand all replies
1.26+0.05(+4.13%)Oct 8 4:00 PMEDT